Alzheimer's Disease Trial, Not Yet Recruiting NCT07114224 Sponsor: Xijing Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07114224
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults between 18 and 75 years old.
  • Healthy male volunteers who weigh at least 50 kg, or healthy female volunteers who weigh at least 45 kg, with a body mass index (BMI) between 19.0 and 28.0 kg/m².
  • People who have been clinically diagnosed with a cognitive disorder such as Alzheimer's disease or mild cognitive impairment (MCI), where symptoms may include memory problems, difficulty concentrating, slowed thinking, or poor language skills.
  • People whose memory, attention, thinking, or language abilities have been found to be below normal levels on neuropsychological tests.
  • People whose blood or cerebrospinal fluid tests show elevated levels of certain proteins linked to cognitive decline (beta-amyloid 1-42, beta-amyloid 1-40, and phosphorylated tau protein).
  • People whose cognitive symptoms have been assessed and other possible causes — such as drug or substance use or environmental factors — have been ruled out.
  • People who have signed an informed consent form agreeing to undergo PET/MR or PET/CT brain imaging scans and to take part in this study voluntarily.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People under 18 years of age, those who are pregnant, or those who are breastfeeding.
  • People with severe liver or kidney problems.
  • People with a known allergy to contrast agents or certain other medications.
  • People diagnosed with viral encephalitis, acute myelitis, idiopathic epilepsy, or antibody-negative autoimmune encephalitis.
  • People diagnosed with any other serious illness.
  • People with a history of alcohol or drug misuse or dependence.
  • People with a history of heart or cardiovascular disease, tumours, blood disorders, or chronic conditions that are not well controlled.
  • People who have a medical reason that prevents them from having a PET/MR scan (confirm with trial site).
  • People with a history of head injury or brain surgery.
  • People with a history of other neurological conditions.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Xijing Hospital
Registry
ClinicalTrials.gov
Start date
15 August 2025
Est. completion
1 June 2027

Primary endpoints

SUVmean; VOI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov